Scientists at F Cubed have developed a novel molecular analyzer which relies on Tecan’s Cavro^® Centris Pump and Cavro Smart Valve to offer straightforward identification of pathogens in a matter of minutes.

The NESDEP IU Molecular Diagnostic System is designed to detect a wide range of pathogens, offering femtomolar specificity from ultra­small sample sizes. F Cubed technical manager Chris Chanelli explained: “The NESDEP analyzer is an integrated unit that enables the user to perform sample preparation and DNA analysis on a biochip. Accurate, precise control of liquid dispensing is required, and this was one of the reasons we chose the Cavro Centris Pump and Cavro Smart Valve.”

“The analysis uses several different fluids, and the Cavro Centris Pump and Cavro Smart Valve play a crucial role in ensuring that these pass through the biochip in the correct order, stabilizing the system before and after the analysis. The pump is extremely accurate and precise in its measurements, which is particularly important when you are working with microliter volumes, as an error of just 0.1 or 0.2 µl can have a big effect on the system’s calculations. The Cavro Centris Pump and Cavro Smart Valve have been a very good choice. The pump has proved very reliable and its consistency is impressive; we know that it is basically going to last forever.”

more about Centris Pump and Cavro Smart Valve

About Tecan

Tecan is a leading global provider of laboratory instruments and solutions in biopharmaceuticals, forensics and clinical diagnostics. The company specializes in the development, production and distribution of automated workflow solutions for laboratories in the life sciences sector. Its clients include pharmaceutical and biotechnology companies, university research departments, and forensic and diagnostic laboratories. As an original equipment manufacturer (OEM), Tecan is also a leader in developing and manufacturing OEM instruments and components that are then distributed by partner companies. Founded in Switzerland in 1980, the company has manufacturing, research and development sites in both Europe and North America and maintains a sales and service network in 52 countries. In 2011, Tecan generated sales of CHF 377 million (USD 424 million; EUR 306 million). Registered shares of Tecan Group are traded on the SIX Swiss Exchange (TK: TECN/Reuters: TECZn.S/Swiss security number: 1210019).

more about Tecan

more news from Tecan